• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail

Patent and Exclusivity Search Results from query on Appl No 021368 Product 004 in the OB_Rx list.

Patent Data

Appl No Prod No Patent No Patent
Drug Substance
Drug Product
Patent Use
N021368 004 5859006 Nov 21, 2017 Y Y
N021368 004 6140329 Jul 11, 2016 Y U - 155
N021368 004 6821975 Nov 19, 2020 Y Y U - 614
N021368 004 6821975 Nov 19, 2020 Y Y U - 533
N021368 004 6943166 Apr 26, 2020 U - 155
N021368 004 7182958 Apr 26, 2020 Y U - 155

Exclusivity Data

There is no unexpired exclusivity for this product.

Additional information:

  1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
  2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be flagged with respect to other claims which may apply.

View a list of all patent use codes
View a list of all exclusivity codes

Return to Electronic Orange Book Home Page

FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:

Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through June 2016
Patent and Generic Drug Product Data Last Updated July 25, 2016